- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on PPD in Portugal
Total 10 results
-
Centro Hospitalar do PortoUniversity of Trás-os-Montes and Alto Douro; Foundation for Science and Technology... and other collaboratorsRecruitingIntermittent Claudication | Peripheral Arterial Disease (PAD)Portugal
-
Bial - Portela C S.A.CompletedParkinson's Disease (PD)Portugal
-
Bial - Portela C S.A.CompletedParkinson's Disease (PD)Portugal
-
Hospital de Sao SebastiaoInstituto de Ciências Biomédicas Abel Salazar; The Novo Nordisk Foundation...RecruitingEnteroendocrine Physiological Changes in Superobese Patients Submitted to Two Different Bariatric Procedures | Determine Whether BPD With DS or SADI-S as Primary or Revisional Surgery is Superior Than the Other as First Choice for the Superobese | Determine Whether or Not Revision...Portugal
-
Bial - Portela C S.A.Completed
-
University Hospital, Basel, SwitzerlandBoehringer IngelheimRecruitingPustular Psoriasis (PP)Germany, Italy, Singapore, Switzerland, Portugal, Turkey
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Czechia, Portugal, Hungary, Germany, Poland
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Netherlands, United Kingdom, Czechia, Portugal, Hungary
-
Novartis PharmaceuticalsActive, not recruitingLocally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutationSpain, Italy, Austria, Netherlands, United Kingdom, Germany, Thailand, France, Belgium, China, Argentina, Greece, Turkey, Malaysia, Portugal, Hungary, Brazil, United States, India
-
Theravance BiopharmaTerminatedParkinson's Disease (PD) | MSA | Symptomatic Neurogenic Orthostatic Hypotension | Pure Autonomic Failure (PAF)United States, Spain, United Kingdom, Canada, France, Estonia, Australia, Israel, Denmark, Italy, Poland, New Zealand, Germany, Ukraine, Austria, Bulgaria, Portugal, Hungary, Russian Federation